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Sir,
We would like to complement dr. Nylænde et al.1 for
the clear design and the strict follow-up of their study.
Unfortunately, the number of patients available for
analysis is small. More importantly, the authors have
erroneously used the SF-36 as a QoL measure. This in-
strument has been developed as a measure of health
status and the risks of its misuse as a QoL measure
have been brought to attention.2 The CLAU-S should
also be regarded as a measure of health status rather
than of QoL. Health status reflects patients’ function-
ing, whereas QoL also reflects a person’s individual
evaluation of functioning.2
The authors estimated ‘‘QoL’’ to improve by 20%
after conservative treatment and 40% after PTA. How-
ever, they did not explain how they arrived at these
percentages and what this would mean for the pa-
tient. Since haemodynamic status has a weak relation-
ship with walking ability and walking ability only
partially predicts a patient’s QoL,3 the question arises
what the clinical relevance of the estimated improve-
ments would be, even if these were statistically
significant.
The putative ‘‘QoL’’ results are expressed in un-
specified numbers instead of actual scores and are,
therefore, difficult to interpret. There were changes
in SF-36 scores from baseline results at 3 months,
which disappeared at 12 months, but surprisingly,
re-appeared for Physical Functioning after 24 months.
This suggests an influence from non-studied variables
on health status. A similar lack of clarity appears for
the CLAU-S scores showing differences for Pain and
Every day life. The meaning and interpretation of
these differences are not commented.
The authors calculated statistical differences in
‘‘QoL’’ scores using the mean values of the two
groups, which illustrate a misunderstanding of the
concept of QoL. QoL is highly individual and1078–5884/000378 + 03 $32.00/0  2007 Published by Elsevier Ltd osumming scores from more than one person elimi-
nates individual values. The use of paired t-tests, to
compare pre- and post-intervention scores within
each participant would have been more in agreement
with the concept of QoL.
In conclusion, the study results confirm transient
benefits with respect to Physical Functioning and
Bodily Pain in the first months after PTA. Improved
haemodynamics after PTA did not translate into mea-
surable benefits with regard to the primary endpoints
of the study at two years.
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